Vizamyl 150MBq/ml, Injektionslösung

7680661100016 CH-66110 Injektionslösung
Vizamyl 150MBq/ml, Injektionslösung
Vizamyl 150MBq/ml, Injektionslösung
Vizamyl 150MBq/ml, Injektionslösung
1 / 3
google

Article details

Package size
10
Selling units
10
Measure
ml
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
21/07/2026
Summary of Product Characteristics
Français
21/07/2026
Summary of Product Characteristics
Italien
21/07/2026

Detailed composition

Substance Quantity Type Category
flutemetamolum(18-F)
150.0 MBQ Substance Wirkstoff (Principe actif)
natrii dihydrogenophosphas dihydricus
- Substance HNIDK
dinatrii phosphas dodecahydricus
- Substance HNIDK
natrii chloridum
- Substance HNIDK
ethanolum anhydricum
0.07 ML Substance HBESI
polysorbatum 80
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
4.1 MG Substance HBESI

Authorization holder

GE Healthcare AG

8152 Opfikon

Authorization information

Swissmedic authorization number
66110
Drug name
Vizamyl, Injektionslösung
Galenic form
LSPA
ATC Code
V09AX04
Authorization status
Z
Dispensing category
A
First authorization
12/04/2017
Authorization expiration date
31/12/9999
IT Number
17.01.1.
Domain
Human medicine
Field of application
PET-Diagnose für die Alzheimer-Krankheit

Package details

Description (FR)
VIZAMYL sol inj 150 MBq/ml 10ml flac
Description (DE)
VIZAMYL Inj Lös 150 MBq/ml 10ml Durchstf
Market launch
12/04/2017
Narcotic (BTM)
No

Other package sizes (1)

VIZAMYL sol inj 150 MBq/ml 15ml flac
15 ML
GTIN: 7680661100023
View
Buy us a coffee Explore the data